Editorial overview: Whither the pharmaceutical industry?

Current Opinion in Drug Discovery and Development

Volumn 8, Issue 3, 2005, Pages 296-297

  Gund, Peter ^a   Maliski, Ed ^b   Brown, Frank ^c  

^a IBM   (United States)

^b AMGEN INC   (United States)

^c R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; ROFECOXIB;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER; DRUG APPROVAL; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEREDITY; INFECTION; LAW SUIT; MEDICAL INFORMATION; PATIENT INFORMATION; PREDICTION;

ANIMALS; DRUG INDUSTRY; DRUG INFORMATION SERVICES; ECONOMICS, PHARMACEUTICAL; HUMANS; TECHNOLOGY, PHARMACEUTICAL;

EID: 17844371348     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (0)